目的 探讨叶酸相关代谢物质与孤独症谱系障碍(ASD)的关系,为ASD的病因及发病机制提供线索和理论依据。方法 采用病例对照研究方法,收集2017年6月—2018年12月在哈尔滨市孤独症定点康复机构进行康复训练的ASD儿童70例作为病例组,1∶1性别、年龄匹配的正常儿童作为对照组。应用液相色谱串联质谱(LC-MS/MS)方法检测两组儿童血浆叶酸相关代谢物质水平,并与ASD儿童临床表型特征进行关联分析。结果 ASD组血浆胱硫醚(Z=2.59)、总谷胱甘肽(tGSH)(t=5.29)、同型半胱氨酸(t=2.23)、半胱氨酸(t=11.37)、蛋氨酸(t=3.14)水平均高于对照组(P<0.05),血浆腺苷(Z=1.20)、胱氨酸(t=1.75)水平在两组间的差异无统计学意义(P>0.05)。ASD血浆tGSH与社交反应量表(SRS)中的社交沟通得分呈正相关(r=0.322,P<0.05)。结论 ASD儿童体内叶酸相关代谢物质表达异常,与ASD临床表型特征评分存在相关性,机制有待进一步探讨。
Abstract
Objective To explore the relationship between folic acid related metabolites and autism spectrum disorder (ASD), so as to provide theoretical basis for the etiology and pathogenesis of ASD. Methods From June 2017 to December 2018, children who received rehabilitation training in designated rehabilitation institutions for autism in Harbin were collected. Seventy autistic children and seventy matched healthy children were enrolled in this case-control study. The levels of folic acid related metabolites in plasma were measured by liquid chromatography tandem-mass spectrometry (LC-MS/MS), and its association with the clinical phenotype of ASD children was analyzed. Results ASD children had higher plasma levels of cystathionine (Z=2.59), total glutathione (tGSH) (t=5.29), homocysteine (Hcy) (t=2.23), cysteine (t=11.37), methionine (t=3.14) compared to healthy control (P<0.05), but the difference in the levels of adenosine(Z=1.20) and cystine(t=1.75) in plasma between the two groups was not significant (P>0.05). The level of tGSH in ASD children was positively correlated with the scores of social communication score in Social Responsiveness Scale (SRS) (r=0.322, P<0.05). Conclusion Abnormal expression of folic acid related metabolites in ASD children is correlated with the scores of clinical phenotypic features of ASD, and the underlying mechanism needs to be further explored.
关键词
孤独症谱系障碍 /
叶酸相关代谢物质 /
病例对照研究
Key words
autism spectrum disorder /
folic acid related metabolites /
case control study
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Maenner MJ, Shaw KA, Bakian AV, et al. Prevalence and characteristics of autism spectrum disorder among children aged 8 years-autism and developmental disabilities monitoring network, 11 Sites, United States, 2018[J]. MMWR Surveill Summ, 2021, 70(11):1-16.
[2] Zhou H, Xu X, Yan W, et al. Prevalence of autism spectrum disorder in China:A nationwide multi-center population-based study among children aged 6 to 12 Years[J]. Neurosci Bull, 2020, 36(9):961-971.
[3] Frye RE, Slattery JC, Quadros EV. Folate metabolism abnormalities in autism:Potential biomarkers[J]. Biomark Med, 2017, 11(8):687-699.
[4] 孙艺, 梁爽, 孙彩虹, 等. 孤独症谱系障碍患儿血清叶酸及其代谢产物与维生素B12水平状况[J]. 中国学校卫生, 2018, 39(3):331-334.
Sun Y, Liang S, Sun CH, et al. Serum folic acid with associated metabolites and vitamin B12 in ASD children:A case-control study[J]. Chin J Sch Health, 2018, 39(3):331-334.
[5] 张纪水, 王芳, 苏怡, 等. 孤独症患儿亚甲基四氢叶酸还原酶基因C677T多态性、出生体质量与患病风险的关联研究[J]. 中华行为医学与脑科学杂志, 2019,28(8):673-677.
Zhang JS, Wang F, Su Y, et al. Association study of MTHFR C677T polymorphism and birth body mass with risk of autism[J]. Chin J Behav Med Brain Sci, 2019,28(8):673-677.
[6] Virk J, Liew Z, Olsen J, et al. Preconceptional and prenatal supplementary folic acid and multivitamin intake and autism spectrum disorders[J]. Autism, 2016, 20(6):710-718.
[7] Juneja M, Sharma S, Mukherjee SB. Sensitivity of the autism behavior checklist in Indian autistic children[J]. J Dev Behav Pediatr, 2010, 31(1):48-49.
[8] Eaves RC, Milner B. The criterion-related validity of the Childhood Autism Rating Scale and the Autism Behavior Checklist[J]. J Abnorm Child Psychol, 1993, 21(5):481-491.
[9] Cen CQ, Liang YY, Chen QR, et al. Investigating the validation of the Chinese Mandarin version of the Social Responsiveness Scale in a Mainland China child population[J]. BMC Psychiatry, 2017, 17(1):51.
[10] James SJ, Cutler P, Melnyk S, et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism[J]. Am J Clin Nutr, 2004, 80(6):1611-1617.
[11] Nagarajan RP, Hogart AR, Gwye Y, et al. Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation[J]. Epigenetics, 2006, 1(4):e1-11.
[12] Guo BQ, Li HB, Ding SB. Blood homocysteine levels in children with autism spectrum disorder:An updated systematic review and meta-analysis[J]. Psychiatry Res, 2020, 291:113283.
[13] Puig-Alcaraz C, Fuentes-Albero M, Calderon J, et al. Increased homocysteine levels correlate with the communication deficit in children with autism spectrum disorder[J]. Psychiatry Res, 2015, 229(3):1031-1037.
[14] Huang F, Chen X, Jiang X, et al. Betaine ameliorates prenatal valproic-acid-induced autism-like behavioral abnormalities in mice by promoting homocysteine metabolism[J]. Psychiatry Clin Neurosci, 2019, 73(6):317-322.
[15] Gatarek P, Rosiak A, Borowczyk K, et al. Higher levels of low molecular weight sulfur compounds and homocysteine thiolactone in the urine of autistic children[J]. Molecules, 2020, 25(4):973.
[16] Ali A, Waly MI, Al-Farsi YM, et al. Hyperhomocysteinemia among Omani autistic children:A case-control study[J]. Acta Biochim Pol, 2011, 58(4):547-551.
[17] Tu WJ, Yin CH, Guo YQ, et al. Serum homocysteine concentrations in Chinese children with autism[J]. Clin Chem Lab Med, 2013, 51(2):e19-22.
[18] Han Y, Xi QQ, Dai W, et al. Abnormal transsulfuration metabolism and reduced antioxidant capacity in Chinese children with autism spectrum disorders[J]. Int J Dev Neurosci, 2015, 46:27-32.
[19] Sun C, Zou M, Zhao D, et al. Efficacy of folic acid supplementation in autistic children participating in structured teaching:An open-label trial[J]. Nutrients, 2016, 8(6):337.
[20] Tan M, Yang T, Zhu J, et al. Maternal folic acid and micronutrient supplementation is associated with vitamin levels and symptoms in children with autism spectrum disorders[J]. Reprod Toxicol, 2020, 91:109-115.
[21] Brieger KK, Bakulski KM, Pearce CL, et al. The association of prenatal vitamins and folic acid supplement intake with odds of autism spectrum disorder in a high-risk sibling cohort, the early autism risk longitudinal investigation (EARLI)[J]. J Autism Dev Disord, 2022,52(6):2801-2811.
[22] Levine SZ, Kodesh A, Viktorin A, et al. Association of maternal use of folic acid and multivitamin supplements in the periods before and during pregnancy with the risk of autism spectrum disorder in offspring[J]. JAMA Psychiatry, 2018, 75(2):176-184.
[23] Di Y, Li Z, Li J, et al. Maternal folic acid supplementation prevents autistic behaviors in a rat model induced by prenatal exposure to valproic acid[J]. Food Funct, 2021, 12(10):4544-4555.
[24] Rossignol DA, Frye RE. The Effectiveness of cobalamin (B12) treatment for autism spectrum disorder:A systematic review and meta-analysis[J]. J Pers Med, 2021, 11(8):784.
[25] 胡晓, 徐海青. 自闭症谱系障碍患儿血清维生素B12、同型半胱氨酸水平及其与病情严重程度的关系[J]. 广西医学, 2020, 42(21):2768-2770.
Hu X, Xu HQ. Serum vitamin B12 and homocysteine levels and their relation with severity of disease in children with autism spectrum disorder[J]. Guangxi Med J, 2020, 42(21):2768-2770.
[26] Hendren RL, James SJ, Widjaja F, et al. Randomized, placebo-controlled trial of methyl B12 for children with autism[J]. J Child Adolesc Psychopharmacol, 2016, 26(9):774-783.
基金
国家自然科学基金面上项目(81072298);广东省科技重大专项计划(2018B030335001)
PDF(619 KB)
